Deviation Investigation Intelligence

The Scenario

The clock starts on the floor. Novulytix — a synthetic medtech & diagnostics manufacturer organized into three divisions: Cardia Rhythm Solutions (Waukegan, IL — implantable cardiac devices), Pharma Manufacturing (Munich, DE — consumable potency products), and Scientific Systems (Marlborough, MA — connected diagnostics) — detects a deviation on Cardia Rhythm Solutions’ Waukegan Line 4: a seal-integrity nonconformance flagged during in-process inspection. The QA Manager owns the investigation, and the regulatory clock — initial assessment in 24 hours, full investigation on a committed timeline — is already running.

The hero case fires — DEV-2026-0412, seal-integrity nonconformance (Major). The deviation backlog surfaces a dozen open cases; AI-powered triage promotes this one to the top, scored on patient-safety impact, batch disposition exposure, and recurrence signal. The Deviation Cockpit assembles the evidence the moment the case opens — batch records, environmental monitoring, equipment and torque logs, the in-process inspection result, and the relevant SOPs — matched to the case by division, line, product family, and semantic similarity, in seconds, not a day of manual compilation.

The reveal — this isn’t the first time. Recurrence mapping connects DEV-2026-0412 to a closed seal-integrity nonconformance on Line 2, a supplier SCAR with no incoming-verification evidence, and an accessory complaint cluster in Scientific Systems — and surfaces that CAPA-NS-2025-118 was closed on training-completion criteria, with the outcome-effectiveness data missing. The deviation investigation is exactly where this failure mode should have been caught — before it became a CAPA-effectiveness gap, a Form 483, and a Warning Letter downstream.

Eight-stage governed investigation. Each deviation advances through 1 Intake & Triage · 2 Risk Classification & Prioritization · 3 Context & Evidence Assembly · 4 Recurrence & Exposure Mapping · 5 Root Cause Analysis · 6 CAPA Candidate Generation · 7 Governed Review & Approval · 8 Closure & Knowledge Capture. Every stage runs a Deviation agent trace, then pauses for a required human reviewer — QA Manager, Site Quality, CAPA Owner — before anything advances. Agents do the legwork; a human always approves — the system drafts the investigation; a human signs it.

Evidence is the product, and it’s defensible. Every record carries a certainty tier (Fact ~98% · Derived ~87% · Hypothesis ~65% · Conjecture ~50%), a confidence level, a risk-impact and actionability tag, and full provenance (source system → source ID → site → owner). Root-cause hypotheses are ranked by evidence strength, never asserted, and the CAPA candidate ships with a complete lineage from the originating deviation through every linked record.

The aha: the investigation that used to take six weeks of tribal-knowledge reconstruction closes in days — with a root cause backed by source-linked evidence, a CAPA linked at 100%, and an audit trail that was complete before the investigation closed.

The Problem

Evidence is fragmented across disconnected systems. When a deviation is detected, the truth lives in batch records, environmental monitoring, equipment and torque logs, in-process inspection results, supplier records, and the SMEs who remember the context. Teams manually compile a defensible package under a regulatory clock, hoping every system tells the same story — and the picture is only as complete as whoever happened to assemble it.

Root cause depends on who’s in the room. Root-cause analysis runs on tribal knowledge and the senior investigator’s memory. The same seal-integrity failure mode that recurred from Line 2 to Line 4 sits in another system’s records, undiscovered, so the investigation treats a recurrence as a first occurrence and the CAPA addresses a symptom instead of the systemic cause.

CAPA linkage and audit-readiness are afterthoughts. CAPA is linked late, or loosely, or on the wrong criteria — closed on training-completion when the outcome-effectiveness data is what would actually defend it. By the time the auditor arrives, the evidence trail is incomplete, inconsistent, or simply missing — and an unsupported investigation narrative is the finding.

Who This Is For

VP Quality, QA managers, compliance officers, CAPA owners, and operations executives in medical device and pharmaceutical manufacturing who need deviation investigations that are fast, traceable, and audit-ready — and who need to know, at the moment of detection, whether they’re looking at a one-off or a recurrence.

Where Deviation Investigation Sits

Deviation Investigation Intelligence is the first line of defense in the quality system — the moment a nonconformance is detected on the floor, before it escalates.

• Detect & Investigate — (this mission) turn a floor deviation into a governed, evidence-backed root cause with a linked CAPA.
• Orchestrate the CAPA — CAPA Orchestration drives the corrective and preventive actions to closure once the root cause is set.
• Stay audit-ready — evidence from every investigation powers continuous audit readiness.
• Coordinate across sites — when the same failure mode spans divisions, multi-site coordination takes over.
• Prevent it upstream — DFx Risk Intelligence catches the design-stage risk before it ever reaches the production floor.

What You’ll Experience

• Deviation Backlog & Prioritization — every open deviation for Novulytix, AI-triaged by patient-safety impact, batch-disposition exposure, and recurrence signal, starting with the hero seal-integrity nonconformance.
• 8-Stage Governed Investigation — a deviation-to-closure flow with a Deviation agent trace and a required human-approval gate at every stage, preserved in an immutable audit trail.
• Context & Evidence Assembly — batch records, environmental monitoring, equipment and torque logs, in-process inspection results, supplier records, and SOPs assembled automatically and matched to the case — not hunted manually.
• Recurrence & Exposure Mapping — the Line-2-to-Line-4 thread surfaced the moment the case opens: the same failure mode connected across lines, divisions, supplier SCARs, and complaint clusters, with the missing CAPA-effectiveness data flagged.
• AI-Guided Root Cause Analysis — ranked root-cause hypotheses with bounded autonomy, each backed by cited evidence and a certainty tier, so the investigator confirms a conclusion instead of reconstructing one.
• CAPA Candidate Generation — corrective and preventive actions drafted with complete lineage from the originating deviation, linked at 100%, scored, and routed for approval — never closed on training-completion alone.
• Evidence & Context Register — a source-linked evidence graph with provenance, certainty, and included/excluded state, plus a transparent missing-evidence queue.
• Governed Review & Approval — QA Manager, Site Quality, and CAPA Owner sign-offs with evidence packets and policy grounding; nothing advances without a human release.
• Trust Receipt & Knowledge Capture — an audit-ready closure package with root cause, evidence consulted, similar cases used, SOPs referenced, human approvals, and confidence — and the institutional knowledge preserved so the next investigation starts smarter than the last.
• Deviation Copilot — scripted, deterministic answers that show reasoning stages, cited evidence, confidence, certainty, actionability, and the approval requirement for every response.
• KPI Scorecard — mean time to close, evidence completeness, CAPA link rate, recurrence detection, and right-first-time investigation rate, each with targets, trends, and AI-generated improvement insights.